中国P站

Infectious bursal disease virus; Very virulent strains; Algeria; Poultry; Control efforts; Vaccination; Molecular epidemiology; Immune evasion

Introduction

Infectious Bursal Disease (IBD) is a highly contagious viral infection that primarily affects young chickens, leading to immunosuppression, poor growth, and increased susceptibility to secondary infections. The disease is caused by the Infectious Bursal Disease Virus (IBDV), which is a member of the Birnaviridae family. IBDV has two distinct forms: classical IBDV (cIBDV) and very virulent IBDV (vvIBDV). The latter is responsible for more severe outbreaks, resulting in higher mortality rates and greater economic losses [1]. In Algeria, poultry farming is a significant agricultural activity, contributing to both local food supply and economic development. Despite the implementation of various control measures, including vaccination and biosecurity protocols, the circulation of very virulent IBDV strains continues to pose a challenge to the poultry industry. Vaccination, while effective to some extent, has not fully prevented outbreaks, suggesting potential issues with vaccine efficacy, immune evasion by the virus, and incomplete herd immunity [2,3]. The persistence of vvIBDV strains in Algeria necessitates a thorough investigation of the molecular epidemiology of the virus, the current status of vaccination campaigns, and the effectiveness of existing control efforts. Understanding the dynamics of vvIBDV transmission and identifying the factors contributing to its persistence are crucial for developing more effective strategies to combat this disease and safeguard the poultry industry [4]. This study aims to explore these issues and provide recommendations for improving control measures in Algeria and similar regions affected by IBD.

Discussion

The persistence of very virulent Infectious Bursal Disease Virus (vvIBDV) strains in Algeria, despite the implementation of control measures, highlights several critical issues in the ongoing fight against this disease. One of the primary challenges identified is the inadequate immune response generated by the current vaccination programs. While vaccines targeting IBDV have been widely used in Algeria, their efficacy appears to be compromised by factors such as incomplete protection and immune evasion by the virus. This suggests that the circulating vvIBDV strains may be undergoing genetic variations that allow them to escape the immune surveillance triggered by vaccination [5,6]. Our study also suggests that the continuous circulation of vvIBDV in poultry populations is exacerbated by the failure to maintain proper biosecurity practices on farms. Inadequate biosecurity measures create opportunities for virus transmission between poultry farms, leading to frequent outbreaks. Furthermore, the movement of infected animals, contaminated equipment, and the introduction of new birds into flocks without adequate quarantine measures likely contribute to the spread of the virus [7]. This situation is compounded by suboptimal surveillance and reporting systems, which delay the detection and containment of outbreaks, allowing the virus to persist undetected [8]. The molecular epidemiology of IBDV in Algeria indicates a complex interplay between the virus, host immunity, and control strategies. Genetic analysis of the virus strains has revealed mutations associated with increased virulence, which may explain the high mortality rates observed in recent outbreak [9]. These mutations could potentially render current vaccines less effective, necessitating the development of new vaccine formulations capable of providing broader protection against evolving strains.

Another important factor contributing to the persistence of vvIBDV is the lack of effective herd immunity. Although vaccination efforts have been widespread, gaps in vaccination coverage and compliance, as well as vaccine administration timing and dosages, can result in incomplete immune protection, allowing the virus to persist in susceptible populations [10]. Moreover, varying environmental conditions, stress, and management practices on poultry farms may further compromise the immune response, leading to outbreaks even in vaccinated flocks.

Conclusion

In conclusion, the persistent circulation of very virulent Infectious Bursal Disease Virus (vvIBDV) strains in Algeria underscores the complexity of controlling this disease in poultry populations. Despite vaccination programs, the virus continues to pose a significant threat to the industry due to issues such as incomplete vaccine protection, immune evasion, inadequate biosecurity practices, and gaps in surveillance. To mitigate the impact of IBD in Algeria and other regions with similar challenges, several steps should be prioritized: Enhanced Surveillance: Improved monitoring of poultry farms to ensure early detection and containment of outbreaks, as well as better reporting systems to track the spread of the virus. Updated Vaccines: Development of more effective vaccines, considering the evolution of IBDV strains and the need for broader cross-protection. Stronger Biosecurity: Strict implementation of biosecurity protocols to prevent the spread of the virus, including better management practices and controlling the movement of animals and equipment. Education and Training: Increasing awareness and training for poultry farmers to improve vaccine administration practices and biosecurity measures. Genetic Research: Ongoing studies into the genetic evolution of vvIBDV strains to anticipate future mutations and guide the development of vaccines with a broader range of protection.

Acknowledgement

None

Conflict of Interest

None

References

1. Lorraine ED, Norrie B (2009) . Nurse Educ Today 29: 654-659.

   , ,

2. Hand H (2006) . Nurs Stand 20: 55-65.

   , ,

3. Kristiina H, Kirsi C, Martin J, Hannele T, Kerttu T, et al. (2016) . Int J Nurs Stud 53: 308-319.

   , ,

4. Connell J O, Glenn G, Fiona C (2014) . J Adv Nurs 70: 2728-2735.

   , ,

5. Dijkstra J, Vleuten CP, Schuwirth LW (2010) . Adv Health Sci Educ Theory Pract 15: 379-393.

   , ,

6. Lambert WT, Vleuten CP (2011) . Med Teach 33: 478-485.

   , ,

7. Janeane D, Cliona T, Amanda A, Andrea B, Jorja C, et al. (2021) . J Acad Nutr Diet 121: 1732-1740.

   , ,

8. Wilkinson TJ, Michael JT (2018) . Adv Med Educ Pract 9: 191-197.

   , ,

9. Nancy EA (2015) . J Med Lib Assoc 103: 152-153.

   , ,

10. Benner P, Tanner C, Chesla C (1992) . Adv Nurs Sci 14: 13-28.

    , ,